12 Infants Die in Clinical Trial For RSV Injection Approved by FDA Panel
A U.S. Food & Drug Administration (FDA) panel recently recommended approval for AstraZeneca’s new monoclonal antibody, which supposedly protects infants and toddlers up to age...